Bayer CropScience's FY23 PAT up 17.5% at 758.2 crore on higher sales
Reports a 4 per cent rise in fourth quarter profits24-05-2023
24-05-2023
BAYER CROPSCIENCE LTD. - 506285 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
We enclose herewith a Statement on Related Party Transactions of the Company for the half year ended as on March 31, 2023 in terms of Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.24-05-2023
BAYER CROPSCIENCE LTD. - 506285 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We send herewith a copy of the News Release that is being issued by the Company today, in connection with the Audited Financial Results for the financial year ended on March 31, 2023. You are requested to kindly take note of the same.24-05-2023
BAYER CROPSCIENCE LTD. - 506285 - Corporate Action-Board to consider Dividend
We wish to inform that at the Board Meeting of the Company held on May 24, 2023, the Board of Directors approved the Audited Financial Results for the year ended March 31, 2023 and recommended a Final Dividend of Rs. 30.00 per share, subject to the approval of the shareholders at the forthcoming Annual General Meeting of the Company.24-05-2023
BAYER CROPSCIENCE LTD. - 506285 - Board Meeting Outcome for Audited Financial Results Of The Company For The Financial Year Ended March 31, 2023 And Adoption Of Audit Report With Unmodified Opinion.
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to furnish the Audited Financial Results of the Company along with the Audit Report for the financial year ended on March 31, 2023 from the Statutory Auditors, Deloitte Haskins & Sells LLP (ICAI Firm Registration No. 117366W/W-100018). Also, pursuant to Regulation (33)(3)(d) of the Listing Regulations, we hereby declare that in the respect of Audited Financial Results for the financial year ended March 31, 2023, the statutory auditors have provided an Audit Report with Unmodified opinion.24-05-2023
BAYER CROPSCIENCE LTD. - 506285 - Board Meeting Outcome for Audited Financial Results Of The Company For The Financial Year Ended March 31, 2023 And Adoption Of Audit Report With Unmodified Opinion.
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to furnish the Audited Financial Results of the Company along with the Audit Report for the financial year ended on March 31, 2023 from the Statutory Auditors, Deloitte Haskins & Sells LLP (ICAI Firm Registration No. 117366W/W-100018). Also, pursuant to Regulation (33)(3)(d) of the Listing Regulations, we hereby declare that in the respect of Audited Financial Results for the financial year ended March 31, 2023, the statutory auditors have provided an Audit Report with Unmodified opinion.24-05-2023
Arya.ag, Bayer partner to promote sustainable agriculture in India
Arya.ag will offer its services to Bayer's network of farmers through its e-market platforms to benefit farmers.23-05-2023
BAYER CROPSCIENCE LTD. - 506285 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding loss/duplicate issue of Share Certificate.19-05-2023
BAYER CROPSCIENCE LTD. - 506285 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding loss/duplicate issue of Share Certificate.17-05-2023
BAYER CROPSCIENCE LTD. - 506285 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
BAYER CROPSCIENCE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve We hereby intimate you that the meeting of the Board of Directors of the Company will be held on Wednesday, May 24, 2023, through audio-visual means, inter alia, to take on record the Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2023 along with the Audit Report and to consider recommendation of final dividend, if any. Further, the trading window of the Company has been closed for all the designated persons pursuant to the Prohibition of Insider Trading Policy of the Company. This is for your information and records.17-05-2023